Sign in to view content

Efficacy, Durability, and Safety of Faricimab in DME: 2-Year Results From the Phase 3 YOSEMITE and RHINE Trials

Jennifer I. Lim, MD, FARVO, FASRS

Video
Published 2022

Related

Suprachoroidal CLS-TA Plus Aflibercept Compared With Aflibercept Monotherapy for DME: Results of a Phase 2 Trial
Michael S. Ip, MD
Annual Meeting Talks
2019
Randomized Trial of Initiating Therapy With Aflibercept, Laser, or Observation for Eyes With Good Vision and Center-Involved DME
Carl W. Baker, MD, FASRS
Annual Meeting Talks
2019
Combination Therapy With Intravitreal Nesvacumab+Aflibercept in Diabetic Macular Edema: The Phase 2 RUBY Trial
Jeffrey S. Heier, MD
Annual Meeting Talks
2018

Category: Diabetic Retinopathy

See more